Skip to main content
Equibles
ADVB logo

ADVB · Advanced Biomed Inc. · Metrics

Track ADVB — free

Use ADVB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADVB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.80 -0.36 (-8.65%)
Rebalance outlook locked
Going-concern doubt — cleared Oct 13, 2026

The latest filing no longer states the doubt (first flagged May 15, 2026).

View the 10-K filed Oct 13, 2026
Market Cap
$6.44M
Shares
1.65M
Volume · Oct 20 22.71K Avg daily vol (3M) 870.96K

ADVB metrics

45 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.80
Market cap
$6.44M

Price action

20 metrics
Price change (1W)
-21.1%
Price change (30D)
-35.7%
Price change (3M)
-53.3%
Price change (6M)
-16.8%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
195.3%
Annualized volatility (3M)
216.1%
Beta
-1.4
RSI (14D)
26.3
Price vs SMA 50
-44.1%
Price vs SMA 200
—
Avg volume (3M)
1.68M
Relative volume
0.2
Average dollar volume
$18.63M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
1.65M

Valuation

12 metrics
P / E (TTM)
0.8
Trailing earnings · reciprocal yield 128.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.6
reciprocal yield 156.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
85.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-4,883.8%
Trailing 12 months
Net margin
5,231.3%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$6.68M
Trailing 12 months
Diluted EPS (TTM)
$5.33
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$4.95
Operating cash flow per diluted share (TTM)
$-2.65
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.85
Stock compensation per diluted share (TTM)
—
Book value per share
$7.43

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+25.5%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
54.4%
Return on assets
48.6%
Debt / equity
0.0
Current ratio
9.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
9.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$385,535
Latest balance sheet
Cash & equivalents
$385,535
Total assets
$13.75M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$1.95M
Capital expenditures (TTM)
$36,090
R&D (TTM)
$961,254
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
1.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
35 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1941029 CUSIP 00752P203 Visit website